Dos revistas médicas de élite retractan documentos sobre coronavirus

The Lancet y The New England Journal of Medicine se retractaron hoy

INDICE: 1. Página 1 | 2. Página 1

Página 1

Lancet. Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673620312903.pdf
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020;S0140-6736(20)31180-6. doi:10.1016/S0140-6736(20)31180-6. pmid:32450107
NEJM. Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. doi:10.1056/NEJMoa2007621. https://www.nejm.org/doi/full/10.1056/NEJMe2020822
Mehra MR, et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. doi:10.1056/NEJMoa2007621. https://www.nejm.org/doi/full/10.1056/NEJMoa2007621
Davey M, Kirchgaessner S, Boseley S. Governments and WHO changed Covid-19 policy based on suspect data from tiny US company. https://www.theguardian.com/world/2020/jun/03/covid-19-surgisphere-who-world-health-organization-hydroxychloroquine
Expression o

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.